載入...
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
Patients with scleroderma receiving Iloprost as a treatment for severe Raynaud’s phenomenon report a reduction in skin tightness, suggesting that this drug inhibits skin fibrosis. Connective tissue growth factor (CTGF), a recently described profibrotic cytokine, acts downstream and in concert with T...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2001
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC203022/ https://ncbi.nlm.nih.gov/pubmed/11457877 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|